Thomas Okarma - Net Worth and Insider Trading

Thomas Okarma Net Worth

The estimated net worth of Thomas Okarma is at least $2 Million dollars as of 2024-05-12. Thomas Okarma is the President and CEO of Geron Corp and owns about 437,060 shares of Geron Corp (GERN) stock worth over $2 Million. Details can be seen in Thomas Okarma's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thomas Okarma has not made any transactions after 2010-06-02 and currently still holds the listed stock(s).

Transaction Summary of Thomas Okarma

To

Thomas Okarma Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thomas Okarma owns 2 companies in total, including Asterias Biotherapeutics Inc (AST) , and Geron Corp (GERN) .

Click here to see the complete history of Thomas Okarma’s form 4 insider trades.

Insider Ownership Summary of Thomas Okarma

Ticker Comapny Transaction Date Type of Owner
AST Asterias Biotherapeutics Inc 2013-09-27 director & President and CEO
GERN Geron Corp 2010-06-02 director & President and CEO

Thomas Okarma Latest Holdings Summary

Thomas Okarma currently owns a total of 1 stock. Thomas Okarma owns 437,060 shares of Geron Corp (GERN) as of June 2, 2010, with a value of $2 Million.

Latest Holdings of Thomas Okarma

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GERN Geron Corp 2010-06-02 437,060 3.80 1,660,828

Holding Weightings of Thomas Okarma


Thomas Okarma Form 4 Trading Tracker

According to the SEC Form 4 filings, Thomas Okarma has made a total of 0 transactions in Geron Corp (GERN) over the past 5 years. The most-recent trade in Geron Corp is the sale of 18,874 shares on June 2, 2010, which brought Thomas Okarma around $102,486.

Insider Trading History of Thomas Okarma

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thomas Okarma Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Thomas Okarma Ownership Network

Ownership Network List of Thomas Okarma

No Data

Ownership Network Relation of Thomas Okarma


Thomas Okarma Owned Company Details

What does Asterias Biotherapeutics Inc do?

Who are the key executives at Asterias Biotherapeutics Inc?

Thomas Okarma is the director & President and CEO of Asterias Biotherapeutics Inc. Other key executives at Asterias Biotherapeutics Inc include other: See Remarks Below Neal C Bradsher , other: See Remarks Below Broadwood Partners Lp , and other: See Remarks Below Broadwood Capital Inc .

Asterias Biotherapeutics Inc (AST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Asterias Biotherapeutics Inc (AST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Asterias Biotherapeutics Inc (AST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Asterias Biotherapeutics Inc (AST)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Asterias Biotherapeutics Inc Insider Transactions

No Available Data

Thomas Okarma Mailing Address

Above is the net worth, insider trading, and ownership report for Thomas Okarma. You might contact Thomas Okarma via mailing address: 230 Constitution Drive, Menlo Park Ca 94025.

Discussions on Thomas Okarma

No discussions yet.